Anmeldung
Gruppen
Forscher/innen
Ergebnisse
MANUEL EDUARDO
MUÑOZ TORRES
CATEDRÁTICO DE UNIVERSIDAD
Novo Nordisk
Copenhagen, Dinamarca
Sie sind in
Zusammenarbeiten
Novo Nordisk
Publikationen in Zusammenarbeit mit Forschern von Novo Nordisk (2)
2015
Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy
Diabetes, Obesity and Metabolism
2012
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): A phase 3, randomised, open-label, treat-to-target non-inferiority trial
The Lancet, Vol. 379, Núm. 9825, pp. 1498-1507
Kontakt
Rechtlicher Hinweis
translate
de
arrow_drop_down
translate
de
arrow_drop_down
es
ca
eu
gl
en
fr